These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26832367)

  • 1. Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.
    Carrier N; Marotta A; de Brum-Fernandes AJ; Liang P; Masetto A; Ménard HA; Maksymowych WP; Boire G
    Arthritis Res Ther; 2016 Feb; 18():37. PubMed ID: 26832367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers.
    Carrier N; de Brum-Fernandes AJ; Liang P; Masetto A; Roux S; Biln NK; Maksymowych WP; Boire G
    RMD Open; 2020 May; 6(1):. PubMed ID: 32371434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.
    van Beers-Tas MH; Marotta A; Boers M; Maksymowych WP; van Schaardenburg D
    Arthritis Res Ther; 2016 Apr; 18():76. PubMed ID: 27037016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3η Protein in serum and synovial fluid correlates with radiographic damage and progression in a longitudinal evaluation of patients with established rheumatoid arthritis.
    Hammam N; Salah S; Kholef EF; Moussa EM; Marotta A
    Mod Rheumatol; 2020 Jul; 30(4):664-670. PubMed ID: 31242798
    [No Abstract]   [Full Text] [Related]  

  • 5. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.
    Meyer O; Nicaise-Roland P; Santos MD; Labarre C; Dougados M; Goupille P; Cantagrel A; Sibilia J; Combe B
    Arthritis Res Ther; 2006; 8(2):R40. PubMed ID: 16469118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab.
    Hirata S; Marotta A; Gui Y; Hanami K; Tanaka Y
    Arthritis Res Ther; 2015 Oct; 17():280. PubMed ID: 26449724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Syversen SW; Gaarder PI; Goll GL; Ødegård S; Haavardsholm EA; Mowinckel P; van der Heijde D; Landewé R; Kvien TK
    Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage.
    Maksymowych WP; van der Heijde D; Allaart CF; Landewé R; Boire G; Tak PP; Gui Y; Ghahary A; Kilani R; Marotta A
    Arthritis Res Ther; 2014 Apr; 16(2):R99. PubMed ID: 24751211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
    Maksymowych WP; Naides SJ; Bykerk V; Siminovitch KA; van Schaardenburg D; Boers M; Landewé R; van der Heijde D; Tak PP; Genovese MC; Weinblatt ME; Keystone EC; Zhukov OS; Abolhosn RW; Popov JM; Britsemmer K; van Kuijk AW; Marotta A
    J Rheumatol; 2014 Nov; 41(11):2104-13. PubMed ID: 25128504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
    Hammer HB; Ødegård S; Syversen SW; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2010 Jan; 69(1):150-4. PubMed ID: 19095696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity.
    Guan SZ; Yang YQ; Bai X; Wang Y; Feng KQ; Zhang HJ; Dong M; Yang HW; Li HQ
    Ann Clin Lab Sci; 2019 Jan; 49(1):57-62. PubMed ID: 30814078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies.
    Guzian MC; Carrier N; Cossette P; de Brum-Fernandes AJ; Liang P; Ménard HA; Boire G
    Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1624-32. PubMed ID: 20617532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
    Raft MB; Hetland ML; Brahe CH; Hørslev-Petersen K; Midtbøll Ørnbjerg L; Junker P; Biln N; Stengaard-Pedersen K; Østergaard M
    Scand J Rheumatol; 2023 Jul; 52(4):342-352. PubMed ID: 35833274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib.
    Shovman O; Gilburd B; Watad A; Amital H; Langevitz P; Bragazzi NL; Adawi M; Perez D; Lidar M; Katz I; Blank M; Biln NK; Marotta A; Shoenfeld Y
    Pharmacol Res; 2019 Mar; 141():623-626. PubMed ID: 30414892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.
    Ma JD; Wei XN; Zheng DH; Mo YQ; Chen LF; Zhang X; Li JH; Dai L
    Arthritis Res Ther; 2015 Oct; 17():289. PubMed ID: 26467222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up.
    Hoff M; Haugeberg G; Odegård S; Syversen S; Landewé R; van der Heijde D; Kvien TK
    Ann Rheum Dis; 2009 Mar; 68(3):324-9. PubMed ID: 18339664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.
    Boire G; Cossette P; de Brum-Fernandes AJ; Liang P; Niyonsenga T; Zhou ZJ; Carrier N; Daniel C; Ménard HA
    Arthritis Res Ther; 2005; 7(3):R592-603. PubMed ID: 15899046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3η: a novel biomarker platform for rheumatoid arthritis.
    Maksymowych WP; Marotta A
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-35-9. PubMed ID: 25365087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
    Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.